Ginkgo Bioworks Holdings Inc
NYSE:DNA
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Ginkgo Bioworks Holdings Inc
NYSE:DNA
|
513.2m USD |
Loading...
|
|
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
87.8B USD |
Loading...
|
|
| US |
|
Ecolab Inc
NYSE:ECL
|
79.8B USD |
Loading...
|
|
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
9.6T JPY |
Loading...
|
|
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
275B CNY |
Loading...
|
|
| CH |
|
Givaudan SA
SIX:GIVN
|
27.5B CHF |
Loading...
|
|
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK |
Loading...
|
|
| US |
|
PPG Industries Inc
NYSE:PPG
|
25.8B USD |
Loading...
|
|
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.3T INR |
Loading...
|
|
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR |
Loading...
|
|
| CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
17.5B EUR |
Loading...
|
Market Distribution
| Min | -4 087 900% |
| 30th Percentile | -5.1% |
| Median | 6% |
| 70th Percentile | 14.8% |
| Max | 1 032 600% |
Other Profitability Ratios
Ginkgo Bioworks Holdings Inc
Glance View
Ginkgo Bioworks Holdings Inc. is at the forefront of the biotechnology revolution, pioneering the field of synthetic biology with a mission to harness the power of organisms to enable sustainable and innovative solutions across multiple industries. Founded in 2008, the company has developed a platform that leverages advanced genetic engineering techniques to design and program living cells, allowing them to produce everything from pharmaceuticals to sustainable materials. This unique approach not only simplifies and accelerates the product development process but also opens up a vast array of market opportunities, positioning Ginkgo as a key player in the bioeconomy. Their partnerships with established firms in sectors like agriculture, food, and pharmaceuticals underscore Ginkgo's capability to transform the way production is approached in these industries. As an investor, Ginkgo Bioworks represents a compelling opportunity, given its robust platform and growing clientele. The company's innovative use of genetic code to solve complex challenges is revolutionizing traditional manufacturing methods, aiming to reduce environmental impact while enhancing efficiency. Ginkgo's commitment to sustainability is reflected in its diverse product applications and collaborations with high-profile partners, which collectively enhance its revenue potential and market reach. With a strong focus on scalability and a seasoned leadership team, Ginkgo is well positioned to capitalize on the expanding demand for biotechnological solutions. This narrative not only highlights the company's technological prowess but also its strategic vision for a sustainable future, making it an attractive investment for those looking to align with forward-thinking, economically sound ventures.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Ginkgo Bioworks Holdings Inc is -188%, which is above its 3-year median of -262.8%.
Over the last 3 years, Ginkgo Bioworks Holdings Inc’s Operating Margin has increased from -690% to -188%. During this period, it reached a low of -690% on Sep 30, 2022 and a high of -131.8% on Jun 30, 2025.